Resultats globals: 2 registres trobats en 0.02 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
26 p, 1.8 MB Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis / Ordulu, Zehra (Department of Pathology, Massachusetts General Hospital, Boston, MA, United States) ; Chai, Hongyan (Department of Genetics, Yale University School of Medicine; New Haven, CT) ; Peng, Gang (Department of Biostatistics, Yale School of Public Health, New Haven, CT) ; McDonald, Anna G (Department of Pathology, Wake Forest Baptist Medical Center, Winston Salem, NC) ; De Nictolis, Michele (Department of Pathology, San Salvatore Hospital, Pesaro, Italy) ; Garcia-Fernandez, Eugenia (Department of Pathology, Hospital Universitario La Paz, IdiPAZ, and Faculty of Medicine, Universidad Autónoma de Madrid, Spain) ; Hardisson, David (Department of Pathology, Hospital Universitario La Paz, IdiPAZ, and Faculty of Medicine, Universidad Autónoma de Madrid, Spain) ; Prat, Jaime (Department of Pathology, Hospital de la Sta Creu i Sant Pau, Barcelona, Spain) ; Li, Peining (Department of Genetics, Yale University School of Medicine; New Haven, CT) ; Hui, Pei (Department of Pathology, Yale University School of Medicine; New Haven, CT) ; Oliva, Esther (Department of Pathology, Massachusetts General Hospital, Boston, MA, United States) ; Buza, Natalia (Department of Pathology, Yale University School of Medicine; New Haven, CT)
Intravenous leiomyomatosis (IVL) is an unusual uterine smooth muscle proliferation that can be associated with aggressive clinical behavior despite a histologically benign appearance. It has some overlapping molecular characteristics with both uterine leiomyoma and leiomyosarcoma based on limited genetic data. [...]
2020 - 10.1038/s41379-020-0546-8
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Vol. 33 (april 2020) , p. 1844-1860  
2.
13 p, 2.3 MB The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients / Gayarre, Javier (Human Genetics Group, Spanish National Cancer Research Center (CNIO)) ; Kamieniak, Marta M. (Human Genetics Group, Spanish National Cancer Research Center (CNIO)) ; Cazorla-Jiménez, Alicia (Department of Pathology, Fundación Jiménez Díaz-IDC Salud) ; Muñoz-Repeto, Ivan (Human Genetics Group, Spanish National Cancer Research Center (CNIO)) ; Borrego, Salud (Biomedical Network Research Centre on Rare Diseases (CIBERER)) ; García-Donas, Jesús (Medical Oncology Service, Oncologic Center Clara Campal) ; Hernando, Susana (Department of Oncology, Fundación Hospital Alcorcón) ; Robles-Díaz, Luis (Familial Cancer Unit and Medical Oncology Department, Hospital 12 de Octubre) ; García-Bueno, José M. (Department of Oncology, Hospital General de Albacete) ; Ramón y Cajal, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Hernández-Agudo, Elena (Breast Cancer Clinical Research Unit, Spanish National Cancer Research Center (CNIO)) ; Heredia Soto, Victoria (Pathology and Translational Oncology Research Laboratories, Hospital La Paz Institute for Health Research (IdiPAZ)) ; Márquez-Rodas, Ivan (Medical Oncology Service, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense) ; Echarri, María José (Medical Oncology Service, Hospital Severo Ochoa) ; Lacambra-Calvet, Carmen (Department of Internal Medicine, Hospital Severo Ochoa) ; Sáez, Raquel (Laboratory of Genetics, Hospital Donostia) ; Cusidó, Maite (Department of Obstetrics and Gynecology, Hospital Universitario Quirón-Dexeus) ; Redondo, Andrés (Department of Medical Oncology, Hospital La Paz IdiPAZ, Madrid) ; Paz-Ares, Luis (Medical Oncology Service, Hospital 12 de Octubre) ; Hardisson, David (Pathology Research Laboratory, Department of Pathology, Hospital La Paz IdiPAZ, and Facultad de Medicina, Universidad Autónoma de Madrid) ; Mendiola, Marta (Pathology and Translational Oncology Research Laboratories, Hospital La Paz Institute for Health Research (IdiPAZ)) ; Palacios, José (Department of Pathology, Hospital Universitario Ramón y Cajal) ; Benítez, Javier (Biomedical Network Research Centre on Rare Diseases (CIBERER)) ; García, María José (Biomedical Network Research Centre on Rare Diseases (CIBERER)) ; Universitat Autònoma de Barcelona. Departament de Medicina
We aimed to evaluate the prognostic and predictive value of the nucleotide excision repair-related gene GTF2H5, which is localized at the 6q24. 2-26 deletion previously reported by our group to predict longer survival of high-grade serous ovarian cancer patients. [...]
2015 - 10.3802/jgo.2016.27.e7
Journal of Gynecologic Oncology, Vol. 27 (november 2015)  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.